JP2013082696A5 - - Google Patents

Download PDF

Info

Publication number: JP2013082696A5
Authority: JP; Japan
Prior art keywords: inhibitor; salt; adenine dinucleotide; flavin adenine; inhibitor according
Prior art date: 2012-09-26
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

JP2012212575A

Other languages

English (en)

Japanese (ja)

Other versions

JP2013082696A (ja

JP5969872B2 (ja

Filing date

2012-09-26

Publication date

2016-03-24

2012-09-26 Application filed filed Critical

2012-09-26 Priority to JP2012212575A priority Critical patent/JP5969872B2/ja

2012-09-26 Priority claimed from JP2012212575A external-priority patent/JP5969872B2/ja

2013-05-09 Publication of JP2013082696A publication Critical patent/JP2013082696A/ja

2016-03-24 Publication of JP2013082696A5 publication Critical patent/JP2013082696A5/ja

2016-08-17 Application granted granted Critical

2016-08-17 Publication of JP5969872B2 publication Critical patent/JP5969872B2/ja

Status Active legal-status Critical Current

2032-09-26 Anticipated expiration legal-status Critical

Links

239000003112 inhibitor Substances 0.000 claims 5
230000002401 inhibitory effect Effects 0.000 claims 5
229940093632 Flavin-Adenine Dinucleotide Drugs 0.000 claims 3
VWWQXMAJTJZDQX-UYBVJOGSSA-N flavin adenine dinucleotide Chemical compound C1=NC2=C(N)N=CN=C2N1[C@@H]([C@H](O)[C@@H]1O)O[C@@H]1CO[P@](O)(=O)O[P@@](O)(=O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C2=NC(=O)NC(=O)C2=NC2=C1C=C(C)C(C)=C2 VWWQXMAJTJZDQX-UYBVJOGSSA-N 0.000 claims 3
235000019162 flavin adenine dinucleotide Nutrition 0.000 claims 3
239000011714 flavin adenine dinucleotide Substances 0.000 claims 3
150000003839 salts Chemical class 0.000 claims 3
239000011780 sodium chloride Substances 0.000 claims 3
230000030833 cell death Effects 0.000 claims 2
210000002919 epithelial cells Anatomy 0.000 claims 2
239000003889 eye drop Substances 0.000 claims 2
239000004480 active ingredient Substances 0.000 claims 1
239000002552 dosage form Substances 0.000 claims 1

JP2012212575A 2011-09-27 2012-09-26 フラビンアデニンジヌクレオチドまたはその塩を有効成分として含有する角膜上皮細胞死の抑制剤 Active JP5969872B2 (ja)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
JP2012212575A JP5969872B2 (ja)	2011-09-27	2012-09-26	フラビンアデニンジヌクレオチドまたはその塩を有効成分として含有する角膜上皮細胞死の抑制剤

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP2011210875		2011-09-27
JP2011210875		2011-09-27
JP2012212575A JP5969872B2 (ja)	2011-09-27	2012-09-26	フラビンアデニンジヌクレオチドまたはその塩を有効成分として含有する角膜上皮細胞死の抑制剤

Publications (3)

Publication Number	Publication Date
JP2013082696A JP2013082696A (ja)	2013-05-09
JP2013082696A5 true JP2013082696A5 (es)	2016-03-24
JP5969872B2 JP5969872B2 (ja)	2016-08-17

Family

ID=47995597

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
JP2012212575A Active JP5969872B2 (ja)	2011-09-27	2012-09-26	フラビンアデニンジヌクレオチドまたはその塩を有効成分として含有する角膜上皮細胞死の抑制剤

Country Status (8)

Country	Link
JP (1)	JP5969872B2 (es)
KR (1)	KR20140082699A (es)
CN (1)	CN103826642B (es)
IN (1)	IN2014DN03350A (es)
MY (1)	MY185239A (es)
SG (2)	SG10201602401PA (es)
TW (1)	TWI561238B (es)
WO (1)	WO2013047567A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2016046734A2 (en) *	2014-09-22	2016-03-31	University Of The Western Cape	Compounds and compositions for treatment of tuberculosis

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2773076B1 (fr) *	1997-12-29	2000-05-19	Chauvin Lab Sa	Utilisation de la flavine-adenine-dinucleotide pour la preparation de compositions ophtalmiques utiles pour le traitement de l'oeil sec
JP4836401B2 (ja) *	2002-04-01	2011-12-14	ロート製薬株式会社	眼科用組成物
JP2004203836A (ja) *	2002-12-26	2004-07-22	Rohto Pharmaceut Co Ltd	眼科用局所適用製剤
JP2005239622A (ja) *	2004-02-26	2005-09-08	Rohto Pharmaceut Co Ltd	角膜障害治療剤
JP4999304B2 (ja) *	2004-09-27	2012-08-15	ロート製薬株式会社	ヒアルロン酸又はその塩を含有する粘膜適用組成物
JP4969052B2 (ja) *	2005-03-31	2012-07-04	小林製薬株式会社	眼科用組成物
CN101301305A (zh) *	2008-05-14	2008-11-12	北京润德康医药技术有限公司	一种黄素腺嘌呤二核苷酸二钠冻干粉针制剂及其制备方法
JP5506357B2 (ja) *	2009-12-02	2014-05-28	ロート製薬株式会社	シリコーンハイドロゲルコンタクトレンズ用眼科組成物
EP2735303A1 (en) *	2012-11-23	2014-05-28	Pilosciences	Hair growth compositions and methods

2012
- 2012-09-26 CN CN201280046826.0A patent/CN103826642B/zh not_active Expired - Fee Related
- 2012-09-26 MY MYPI2014000895A patent/MY185239A/en unknown
- 2012-09-26 SG SG10201602401PA patent/SG10201602401PA/en unknown
- 2012-09-26 KR KR1020147009783A patent/KR20140082699A/ko not_active Application Discontinuation
- 2012-09-26 JP JP2012212575A patent/JP5969872B2/ja active Active
- 2012-09-26 SG SG11201400947XA patent/SG11201400947XA/en unknown
- 2012-09-26 WO PCT/JP2012/074662 patent/WO2013047567A1/ja active Application Filing
- 2012-09-26 TW TW101135280A patent/TWI561238B/zh not_active IP Right Cessation
2014
- 2014-04-25 IN IN3350DEN2014 patent/IN2014DN03350A/en unknown

Similar Documents

Publication	Publication Date	Title
CY1124000T1 (el)	2022-05-27	Υποκατεστημενες 5-φθορο-1η-πυραζολοπυριδινες σε κρυσταλλικη μορφη
PH12015502539A1 (en)	2016-02-22	Cenicriviroc compositions and methods of making and using the same
CR20130560A (es)	2014-02-18	Compuestos de bezotiazol y su uso farmacéutico
EA201490419A1 (ru)	2014-05-30	Соединения для лечения и профилактики респираторного синцитиального вирусного заболевания
PH12014502041A1 (en)	2014-11-24	Heterocyclyl compounds as mek inhibitors
UA113651C2 (xx)	2017-02-27	Макроциклічні пурини для лікування вірусних інфекцій
EA201890236A1 (ru)	2018-10-31	Полициклические карбамоилпиридоновые соединения и их фармацевтическое применение
UY34918A (es)	2014-02-28	Nuevos ácidos 5-aminotetrahidroquinolin-2-carboxílicos y su uso
BR112014033080A2 (pt)	2017-06-27	inibidores do vírus da hepatite c
EA201591195A1 (ru)	2015-10-30	Новые хинолоновые производные
EA201590667A1 (ru)	2015-07-30	Ациламинопиримидиновые производные для лечения вирусных инфекций и других заболеваний
EA201590862A1 (ru)	2016-05-31	Фармацевтические композиции
EA201400976A1 (ru)	2015-02-27	Бензодиоксаны в комбинации с другими активными средствами для ингибирования продуцирования лейкотриена
NZ703989A (en)	2017-04-28	Alkoxy pyrazoles as soluble guanylate cyclase activators
AR085856A1 (es)	2013-10-30	Formas cristalinas del acido (2s)-2-ter-butoxi-2-(4-(2,3-dihidropirano[4,3,2-de]quinolin-7-il)-2-metilquinolin-3-il)acetico
EA201590562A1 (ru)	2015-07-30	Бензамиды
EA201201658A1 (ru)	2013-06-28	Производные пиперидина и их применение для лечения метаболических нарушений
EA201792072A3 (ru)	2018-09-28	Производные глутаримидов, их применение, фармацевтическая композиция на их основе, способы их получения
NZ628408A (en)	2017-09-29	Ingenol derivatives in reactivation of latent hiv virus
AR090806A1 (es)	2014-12-10	Glucosidos de pirazol y su utilizacion en el tratamiento de la diabetes tipo i y ii
EA201490573A1 (ru)	2014-06-30	Соединение бензотиазолона
JP2013082696A5 (es)	2016-03-24
UY33806A (es)	2012-07-31	?compuestos novedosos de imidazoquinolina, composiciones que los contienen y su uso en el tratamiento de enfermedades mediadas por tlr7?
WO2014124092A3 (en)	2014-10-23	Lamivudine crystalline salts
TH162256A (th)	2017-05-04	ตัวยับยั้งการตายของเซลล์เนื้อเยื่อบุผิวของกระจกตาซึ่งมีฟลาวินแอดีนีนไดนิวคลีโอไทด์หรือเกลือของสิ่งเหล่านี้ในฐานะเป็นสารออกฤทธิ์